<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166627">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02084498</url>
  </required_header>
  <id_info>
    <org_study_id>StenoABC</org_study_id>
    <nct_id>NCT02084498</nct_id>
  </id_info>
  <brief_title>Advanced Carbohydrate Counting and Automated Bolus Calculation</brief_title>
  <official_title>A Randomized Controlled Large Study of Flexible Intensified Insulin Therapy (FIIT) With Carbohydrate Counting (CHC) Versus FIIT With Carbohydrate Counting and Automated Bolus Calculation (ABC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steno Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Steno Diabetes Center</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize, that non-optimally treated carbohydrate counting-naïve
      patients with type 1 diabetes can achieve better metabolic control by counting
      carbohydrates, and that the metabolic control can be further improved with concurrent use of
      Accu-Chek Aviva Expert. Additionally, the investigators propose that carbohydrate counting
      will lead to better quality of life as a result of fewer restrictions when eating and less
      variation in blood glucose. Finally the investigators hypothesize that the use of Accu-Chek
      Aviva Expert will lead to fewer hypoglycemic episodes.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of serious hypoglycemic events</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Frequency of glucose below, in or above target 4-8 mmol/l assessed by blinded Continuous Glucose Monitoring 6 days before study start and 6 days before ending the study</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Frequency of blood glucose measurements assessed by meter download before randomization and at each visit during the study</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Treatment Satisfaction</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by Diabetes Treatment Satisfaction Questionnaire</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">196</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>ACC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Training in advanced carbohydrate counting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACC + ABC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Training in advanced carbohydrate counting plus the use of an automated bolus calculator.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automated bolus calculator</intervention_name>
    <description>Training in Advanced Carbohydrate Counting and the use of an automated bolus calculator according to the BolusCal concept.</description>
    <arm_group_label>ACC + ABC</arm_group_label>
    <other_name>Accu-Chek Aviva Expert, Roche Diagnostics</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Advanced Carbohydrate Counting</intervention_name>
    <description>Training in advanced carbohydrate counting.</description>
    <arm_group_label>ACC</arm_group_label>
    <arm_group_label>ACC + ABC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with type 1 diabetes

          -  Age 18-65 years

          -  Diabetes duration more than 12 months

          -  Multiple Daily Injections therapy (fast acting analog for meals; long acting analog
             as basal)

          -  HbA1c between 8.0% and 10.5%

        Exclusion Criteria:

          -  Present or former practice of carbohydrate counting

          -  Gastroparesis

          -  Pregnancy or nursing
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva E Hommel, MD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Steno Diabetes Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Steno Diabetes Center</name>
      <address>
        <city>Gentofte</city>
        <zip>2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Schmidt S, Meldgaard M, Serifovski N, Storm C, Christensen TM, Gade-Rasmussen B, Nørgaard K. Use of an automated bolus calculator in MDI-treated type 1 diabetes: the BolusCal Study, a randomized controlled pilot study. Diabetes Care. 2012 May;35(5):984-90. doi: 10.2337/dc11-2044. Epub 2012 Feb 16.</citation>
    <PMID>22344610</PMID>
  </reference>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>March 11, 2014</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Steno Diabetes Center</investigator_affiliation>
    <investigator_full_name>Eva Hommel</investigator_full_name>
    <investigator_title>Senior Consultant</investigator_title>
  </responsible_party>
  <keyword>Automated bolus calculator (ABC)</keyword>
  <keyword>Advanced carbohydrate counting (ACC)</keyword>
  <keyword>Patient empowerment</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
